Author Correction: Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs
Virginie Baylot, Thi Khanh Le, David Taïeb, Palma Rocchi, Laurence Colleaux
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCRISPR and Genetic Engineering
Correction to: Communications Biology 10.1038/s42003-024-06121-9, published online 23 April 2024
In this article, the ‘Competing Interest’ statement was incorrectly given as ‘The authors declare no competing interests’ but should have been ‘P. Rocchi, D. Taieb and L. Colleaux are cofounders of SilonTx (https://silontx.com), a biotech company started in April 2024 focusing on precision medicine and nucleic acid therapeutics. The other authors declare no competing interests’. The original article has been corrected.